Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 2
1975 2
1977 1
1979 1
1980 1
1981 1
1984 1
2015 1
2017 1
2018 1
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Evolving role of immunotherapy in small cell lung cancer.
Barrows ED, Blackburn MJ, Liu SV. Barrows ED, et al. Among authors: blackburn mj. Semin Cancer Biol. 2022 Feb 19:S1044-579X(22)00048-7. doi: 10.1016/j.semcancer.2022.02.021. Online ahead of print. Semin Cancer Biol. 2022. PMID: 35192928 Review.
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
Lynce F, Blackburn MJ, Zhuo R, Gallagher C, Hahn OM, Abu-Khalaf M, Mohebtash M, Wu T, Pohlmann PR, Dilawari A, Tiwari SR, Chitalia A, Warren R, Tan M, Shajahan-Haq AN, Isaacs C. Lynce F, et al. Among authors: blackburn mj. Cancer. 2021 Oct 1;127(19):3622-3630. doi: 10.1002/cncr.33620. Epub 2021 Jun 22. Cancer. 2021. PMID: 34157782 Clinical Trial.
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.
In GK, Nallagangula A, Choi JS, Tachiki L, Blackburn MJ, Capone S, Bollin KB, Reuben DY, Shirai K, Zhang-Nunes S, Ragab O, Terando A, Hu JC, Lee H, Bhatia S, Chandra S, Lutzky J, Gibney GT. In GK, et al. Among authors: blackburn mj. J Immunother Cancer. 2022 May;10(5):e004839. doi: 10.1136/jitc-2022-004839. J Immunother Cancer. 2022. PMID: 35545318 Free PMC article.
16 results